the Republic of Moldova will add vaccination against human papillomavirus (HPV) to the routine immunization schedule

Moldova (Republic Of)
6 February 2017

Vaccination against human papillomavirus (HPV) will be added to the routine immunization schedule in the Republic of Moldova in November 2017. Timely vaccination against HPV prevents infection with viruses that are the leading cause of cervical and other cancers. The Ministry of Health’s decision to introduce the vaccine followed the recommendation of the country’s independent national immunization technical advisory committee (NITAG) based on its thorough review of available evidence. 

Flag_of_Moldova.svg.png

WHO/Europe support for the decision-making process has included organization of a national conference and stakeholders’ meeting on HPV disease and vaccines on 29–30 September 2016 in Chisinau, Republic of Moldova. The conference brought together public health professionals and clinicians (obstetricians/gynaecologists, paediatricians, oncologists), medical academia, Ministry of Health officials, representatives of the Medical and Pharmaceutical State University, the national immunization programme, United Nations agencies and other stakeholders. They discussed the burden of cervical cancer in the Republic of Moldova and the experience of countries globally and in the European Region in implementing the HPV vaccine, including country efforts to address vaccine safety concerns, as well as other challenges and lessons learnt.

Burden of HPV-related disease

HPV poses a serious burden on public health in the Republic of Moldova. According to WHO estimates, HPV caused cervical cancer in more than 470 women and was responsible for 210 deaths in the country in 2012 alone. Cervical cancer is the third most prevalent of all cancers among women. The Republic of Moldova is among the top 5 countries in the WHO European Region with the highest cervical cancer mortality rates. The introduction of HPV vaccine along with implementation of other preventive interventions will help significantly reduce morbidity and mortality owing to cervical cancer and other HPV-related conditions.
By 2016, 28 countries of the WHO European Region and 67 countries globally introduced HPV vaccine into routine immunization programmes; and after 10 years and more than 200 million doses used, there is strong evidence to support that HPV vaccine is effective and safe. The successful introduction of HPV vaccine requires implementation of intensified public awareness activities and active involvement of health workers.

Related News & Events

  • Moldova (Republic Of)

    Evaluation of The Moldovan NITAG's Performance

    26.05.2016

    As part of its collaboration with WHO EURO to strengthen National Immunization Technical Advisory Groups (NITAGs), a team of the SIVAC Initiative / HPID Center visited the Moldovan NITAG from 18th to 20th May 2016. The objective was to evaluate the Moldovan NITAG’s performance through the implementation of the evaluation tool developed by HPID in 2015.

    Read more
  • Moldova (Republic Of)

    Tiberiu Holban - Questions to the chair of the NITAG of Moldova

    26.10.2015

    The NITAG of Moldova is relatively new. It was established in October 2013 after a long discussion process with the Ministry of Health and people involved in the national immunization programme. The committee is composed of 32 members, including ex-officio members who are representatives of national bodies involved in immunization. Core members are doctors specialized in different disciplines all related to vaccinologie: infectious diseases, pediatrics, immunology, public health etc.
    The committee has already met three times since it was established and members have discussed several topics such as:

    • The introduction of the inactivated polio vaccine (IPV) and HPV vaccine
    • The removal of mandatory BCG vaccination
    • Vaccination against Hepatitis A and Flu among risk groups
    • Post-introduction evaluation of Pneumococcal Conjugate Vaccine and rotavirus vaccine

     

    Read more
  • Chile
    Functioning

    Chile's NITAG documents the results of the committee's evaluation

    02.07.2019

    In this article, we describe the structure, functioning and work processes of Chile’s NITAG (CAVEI) and assess its functionality, quality of work processes and outputs, and integration of the committee into the Ministry of Health policy process using the Assessment tool for National Immunization Technical Advisory Groups.

    Read more